Professional Documents
Culture Documents
Antidepressant Drugs
Antidepressant Drugs
Antidepressant Drugs
Available Antidepressants
Desipramine
Amoxepine
Trimipramine
Maprotiline
Clomipramine Amitriptyline Nortriptyline Protriptyline
2) Monoamine Oxidase Inhibitors (MAOIs)
Tranylcypramine Phenelzine
Moclobemide
3) Serotonin Selective Reuptake Inhibitors (SSRIs)
Fluoxetine
Fluvoxamine
Sertraline Paroxetine
Citalopram
4) Dual Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)
Venlafaxine
Duloxetine
5) Serotonin-2 Antogonist and Reuptake Inhibitors (SARIs)
Nefazodone
Trazodone
6) Norepinephrine and Dopamine Reuptake Inhibitor (NDRI)
Bupropion
7) Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Mirtazapine
8) Noradrenalin Specific Reuptake Inhibitor (NRI)
Reboxetine
9) Serotonin Reuptake Enhancer
Tianeptine
Amine Hypothesis
Anti-muscarinic
Serotonin
Norepinephrine
Dopamine
+++
+++
+++
++
Amoxapine
++
++
++
Bupropion
+, 0
+, 0
Citalopram
+++
+++
++
+++
+++
+++
Doxepin (Sinequan)
+++
+++
++
Fluoxetine (Prozac)
+++
0, +
0, +
Fluvoxamine (Luvox)
+++
Imipramine (Tofranil)
++
++
+++
++
Maprotiline
++
++
+++
Mirtazapine2
+++
Nefazodone
++
+++
+, 0
Nortriptyline
++
++
+++
++
Paroxetine (Seroxat)
+++
Protriptyline
++
+++
Sertraline (Zoloft)
+++
Trazodone (Mesyrel)
+++
++
Venlafaxine (Efexor)
+++
++
0, +
Drug
Amitriptyline
Clomipramine
Desipramine
Anti-muscarinic
Serotonin
Norepinephrine
Dopamine
+++
+++
+++
++
Amoxapine
++
++
++
Bupropion
+, 0
+, 0
Citalopram
+++
+++
++
+++
+++
+++
+++
+++
++
Fluoxetine
+++
0, +
0, +
Fluvoxamine
+++
Imipramine (Tofranil)
++
++
+++
++
Maprotiline
++
++
+++
Mirtazapine2
+++
Nefazodone
++
+++
+, 0
Nortriptyline
++
++
+++
++
Paroxetine
+++
Protriptyline
++
+++
Sertraline
+++
+++
++
+++
++
0, +
Drug
Amitriptyline
Clomipramine
Desipramine
Doxepin (Sinequan)
Trazodone (Mesyrel)
Venlafaxine
Anti-muscarinic
Serotonin
Norepinephrine
Dopamine
+++
+++
+++
++
Amoxapine
++
++
++
Bupropion
+, 0
+, 0
Citalopram
+++
+++
++
+++
+++
+++
+++
+++
++
Fluoxetine
+++
0, +
0, +
Fluvoxamine
+++
Imipramine (Tofranil)
++
++
+++
++
Maprotiline
++
++
+++
Mirtazapine2
+++
Nefazodone
++
+++
+, 0
Nortriptyline
++
++
+++
++
Paroxetine
+++
Protriptyline
++
+++
Sertraline
+++
Trazodone (Mesyrel)
+++
++
Venlafaxine (Efexor)
+++
++
0, +
Drug
Amitriptyline
Clomipramine
Desipramine
Doxepin (Sinequan)
Anti-muscarinic
Serotonin
Norepinephrine
Dopamine
+++
+++
+++
++
Amoxapine
++
++
++
Bupropion
+, 0
+, 0
Citalopram
+++
+++
++
+++
+++
+++
Doxepin (Sinequan)
+++
+++
++
Fluoxetine (Prozac)
+++
0, +
0, +
Fluvoxamine (Luvox)
+++
Imipramine (Tofranil)
++
++
+++
++
Maprotiline
++
++
+++
Mirtazapine2
+++
Nefazodone
++
+++
+, 0
Nortriptyline
++
++
+++
++
Paroxetine (Seroxat)
+++
Protriptyline
++
+++
Sertraline (Zoloft)
+++
Trazodone (Mesyrel)
+++
++
Venlafaxine (Efexor)
+++
++
0, +
Drug
Amitriptyline
Clomipramine
Desipramine
OUT
Cl-
Na+
Cl-
Na+
GABAA receptor
Inhibition
IN
Glutamate/AMPA
receptor
Excitation
Cerebral cortex
Sensory input
Information integration
cognition, thought,
mood, emotion
acetylcholine norepinephrine
serotonin
dopamine
Motor output
histamine
Arousal:
1. Processing signals relate to plain & pleasure. Regulating
body homeostasis
2. Emotion and feeling
3. Attention
4. Wakefulness & sleep
5. learning
The construction of consciousness.
Fast
Slow
milliseconds
seconds
1/1000 of a second !
Out
NH2
7 transmembrane
domain receptor
In
2nd messengers
COOH
Ionotropic
Metabotropic
The monoamines
Dopamine
Epinephrine (adrenergic)
Norepinephrine (noradrenergic)
Serotonin
Neurotransmitter
receptors
Neurotransmitter
receptors
Ion pumps
Second messengers
Protein kinases
Ion channels
Transcription Factors
Cell nucleus
7-transmembrane-domain receptors
Excitatory input
Glutamate
Neuromodulatory
inputs
NE
GluR
b1
DA
Neuromodulatory
inputs
ACh
D1
cAMP
M1
Ca2+
Ca2+-dependent
Kinases/phosphatases
PKC
Hist
PKA
H2
5-HT
IP3 + DG
5-HT2C
Down-stream substrates
Gene expression
Hist
H1
Long-term synaptic modification
Catecholamines
Norephinephrine
NE System
Almost all NE pathways in the brain originate from the cell
bodies of neuronal cells in the locus coereleus in the
midbrain, which send their axons diffusely to the cortex,
cerebellum and limbic areas (hippocampus, amygdala,
hypothalamus, thalamus).
Mood: -- higher functions performed by the
cortex.
Cognitive function: -- function of cortex.
Drive and motivation: -- function of brainstem
Memory and emotion: -- function of the
hippocampus and amygdala.
Endocrine response: -- function of hypothalamus.
and b receptors.
Antidepressant
Selective inhibitor,
reboxetine
Reuptake of NE
Out
GABA
ClGABA
Cl-
PO4
Cl-
In
GABA + cAMP
GABA + NE
GABA
response
GABA
time
Noradrenergic potentiation of cerebellar Purkinje cell responses
to GABA: cAMP as intracellular intermediary.
NE
b-adrenergic
receptor
GABAA receptor
b1
Gs
PO4
AC
cAMP
PKA reg
ATP
PKA cat
Out
GABA
ClGABA
Cl-
PO4
Cl-
In
POSTSYNAPTIC MODULATION
Presynaptic
Postsynaptic
Before LTP
After LTP
After LTP
Postsynaptic
LTP decays
NE
Glu
Stabilization of LTP
PKA
Inhibition of
protein phosphatase I
cAMP
INDOLEAMINE
SEROTONIN (5-HT)
Serotonin System
As with the NE system, serotonin neurons located
in the pons and midbrain (in groups known as
raphe nuclei) send their projections diffusely to the
cortex, hippocampus, amygdala, hypothalamus,
thalamus, etc. --same areas implicated in
depression. This system is also involve in:
Anxiety.
Sleep.
Sexual behavior.
Rhythms (Suprachiasmatic nucleus).
Temperature regulation.
CSF production.
PRESYNAPTIC
MODULATION
NE
5-HT
1-AR
5-HT1
5-HT2
5-HT3
NE
Mianserin
Humans
Serotonin - a chemical manifestation of personality
High level of serotonin: compulsives
obsessive-compulsive disorders
e.g. compulsive hand-washing
Catecholamines
Dopamine
Behavioural control
Dopamine is the brains motivational chemical. It works on
glutamate synapses to modulate their excitability.
A shortage of brain dopamine causes an indecisive
personality, unable to initiate even the bodys own
movement. Parkinsons disease. Time stops.
L-DOPA therapy. Awakenings film. (Oliver Sachs)
Excess dopamine, more arousal. Attention defecit
disorder. May cause schizophrenia.
Dopamines action is essential for drug addiction.
DARP-32
Dopamine and cAMP-regulated phosphoprotein
Molecular weight, 32 kDa
DARP-32 is a molecular integrator
Genetics
Polymorphisms of genes involved in aminergic
(dopamine/serotonin) neurotransmission
Effects on personality?
Dopamine D4 receptor - novelty seeking
Promoter of serotonin transporter gene - harm avoidance/anxiety
D4 dopamine receptor
D4 dopamine receptor
Genetics
The larger the number of loop 3 repeats, the more ineffective
the dopamine D4 receptor in signalling
Long D4DR genes imply low responsiveness to dopamine
short D4DR gene imply high responsiveness
The idea
People with long D4DR genes have low responsiveness to
dopamine, so they need to take a more adventurous approach to
life to get the same dopamine buzz that short-gened people get
from simple things.
Obviously, this is just one possible factor of many.
Dont oversimplify!
Neurotrophin Hypothesis
Chronic, severe